CURE spoke with two physicians, on behalf of the Hairy Cell Leukemia Foundation, about the basics of the disease, as well as its diagnosis and treatment, and also about how patients can learn more about clinical trials.
FDA Approves Tibsovo Plus Vidaza For Patients With Newly Diagnosed Acute Myeloid Leukemia
Surgery Timing May Have ‘Little Effect’ on Time to Ovarian Cancer Disease Progression
Will My Daughter Be a Triple-Positive Breast Cancer Pioneer?
Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations